AU2001276860A1 - Medicaments for chemotherapeutic treatment of disease - Google Patents
Medicaments for chemotherapeutic treatment of diseaseInfo
- Publication number
- AU2001276860A1 AU2001276860A1 AU2001276860A AU7686001A AU2001276860A1 AU 2001276860 A1 AU2001276860 A1 AU 2001276860A1 AU 2001276860 A AU2001276860 A AU 2001276860A AU 7686001 A AU7686001 A AU 7686001A AU 2001276860 A1 AU2001276860 A1 AU 2001276860A1
- Authority
- AU
- Australia
- Prior art keywords
- medicaments
- disease
- chemotherapeutic treatment
- chemotherapeutic
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/062—Photodynamic therapy, i.e. excitation of an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
- C07D311/82—Xanthenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/22—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22051—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
- A61B2017/22062—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation to be filled with liquid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/22—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22082—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for after introduction of a substance
- A61B2017/22087—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for after introduction of a substance photodynamic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/19—Halogen containing
- Y10T436/193333—In aqueous solution
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Radiology & Medical Imaging (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Pyrane Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21846400P | 2000-07-14 | 2000-07-14 | |
| US60218464 | 2000-07-14 | ||
| US09900355 | 2001-07-06 | ||
| US09/900,355 US7648695B2 (en) | 1998-08-06 | 2001-07-06 | Medicaments for chemotherapeutic treatment of disease |
| PCT/US2001/021585 WO2002005812A1 (fr) | 2000-07-14 | 2001-07-10 | Medicaments pour le traitement chimiotherapeutique de maladies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001276860A1 true AU2001276860A1 (en) | 2002-01-30 |
Family
ID=26912931
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001276860A Abandoned AU2001276860A1 (en) | 2000-07-14 | 2001-07-10 | Medicaments for chemotherapeutic treatment of disease |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US7648695B2 (fr) |
| EP (1) | EP1311261B1 (fr) |
| JP (1) | JP4989837B2 (fr) |
| AR (1) | AR029721A1 (fr) |
| AT (1) | ATE384522T1 (fr) |
| AU (1) | AU2001276860A1 (fr) |
| CA (1) | CA2415280C (fr) |
| DE (1) | DE60132600T2 (fr) |
| ES (1) | ES2300344T3 (fr) |
| MX (1) | MXPA03000353A (fr) |
| WO (1) | WO2002005812A1 (fr) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7390668B2 (en) * | 1996-10-30 | 2008-06-24 | Provectus Pharmatech, Inc. | Intracorporeal medicaments for photodynamic treatment of disease |
| US8974363B2 (en) * | 1997-12-11 | 2015-03-10 | Provectus Pharmatech, Inc. | Topical medicaments and methods for photodynamic treatment of disease |
| US8557298B2 (en) * | 1998-08-06 | 2013-10-15 | Provectus Pharmatech, Inc. | Medicaments for chemotherapeutic treatment of disease |
| US6986740B2 (en) * | 1998-11-02 | 2006-01-17 | Xantech Pharmaceuticals, Inc. | Ultrasound contrast using halogenated xanthenes |
| US8470296B2 (en) * | 1998-12-21 | 2013-06-25 | Provectus Pharmatech, Inc. | Intracorporeal medicaments for high energy phototherapeutic treatment of disease |
| US20020001567A1 (en) * | 1998-12-21 | 2002-01-03 | Photogen, Inc. | Intracorporeal medicaments for high energy phototherapeutic treatment of disease |
| US20050053895A1 (en) | 2003-09-09 | 2005-03-10 | The Procter & Gamble Company Attention: Chief Patent Counsel | Illuminated electric toothbrushes emitting high luminous intensity toothbrush |
| CA2596355C (fr) | 2005-01-31 | 2015-01-06 | Ception Therapeutics, Inc. | Inhibiteurs du facteur de necrose tumorale |
| ES2380239T3 (es) | 2005-11-09 | 2012-05-09 | Klox Technologies Inc. | Composiciones y procedimientos para blanqueo dental |
| US20100266989A1 (en) | 2006-11-09 | 2010-10-21 | Klox Technologies Inc. | Teeth whitening compositions and methods |
| NZ631218A (en) | 2008-11-07 | 2016-03-31 | Klox Technologies Inc | Combination of an oxidant and a photoactivator for the healing of wounds |
| HRP20171797T1 (hr) | 2009-07-17 | 2018-01-26 | Klox Technologies Inc. | Antibakterijski oralni pripravak |
| KR101494055B1 (ko) | 2009-09-18 | 2015-02-16 | 프로벡투스 파마슈티컬스 인코포레이티드 | 4,5,6,7-테트라클로로-3'',6''-다이하이드록시-2'',4'',5'',7''- 테트라요오도-3h-스피로[이소벤조푸란-1,9''-잔텐]-3-온(로즈 벤갈) 및 관련 잔텐의 합성 방법 |
| US9273022B2 (en) | 2009-09-18 | 2016-03-01 | Provectus Pharmaceuticals, Inc. | Process for the synthesis of 4,5,6,7-tetrachloro-3′,6′-dihydroxy-2′, 4′, 5′7′-tetraiodo-3H-spiro[isobenzofuran-1,9′-xanthen]-3-one (Rose Bengal) and related xanthenes |
| CN103476943A (zh) | 2011-03-10 | 2013-12-25 | 普罗维克图斯药品公司 | 用于增强治疗癌症的局部和全身性免疫调节疗法的组合 |
| US11116841B2 (en) | 2012-04-20 | 2021-09-14 | Klox Technologies Inc. | Biophotonic compositions, kits and methods |
| US20130281913A1 (en) | 2012-04-20 | 2013-10-24 | Klox Technologies Inc. | Biophotonic compositions and methods for providing biophotonic treatment |
| MX351267B (es) | 2012-09-14 | 2017-10-06 | Valeant Pharmaceuticals Int Inc | Composiciones y metodos para blanqueamiento dental. |
| SMT202000452T1 (it) | 2012-09-21 | 2020-09-10 | Intensity Therapeutics Inc | Metodo di trattamento del cancro |
| US20140276354A1 (en) | 2013-03-14 | 2014-09-18 | Klox Technologies Inc. | Biophotonic materials and uses thereof |
| ES2964399T3 (es) | 2018-05-16 | 2024-04-05 | Provectus Pharmatech Inc | Actividad antitumoral in vitro y xenoinjerto de un xanteno halogenado contra tumores sólidos pediátricos refractarios |
| MX2022005828A (es) * | 2019-11-19 | 2022-07-04 | Provectus Pharmatech Inc | Composicion y metodo para tratamiento de canceres hematologicos. |
| US12064507B2 (en) | 2019-11-19 | 2024-08-20 | Provectus Pharmatech, Inc. | Composition and method for oral treatment of leukemia |
| US11419844B2 (en) | 2019-11-19 | 2022-08-23 | Provectus Pharmatech, Inc. | Halogenated xanthene composition and method for treating hematologic cancers |
| CA3172124A1 (fr) * | 2020-03-26 | 2021-09-30 | Aru NARENDRAN | Utilisations de xanthenes halogenes en oncologie et virologie |
| US11938182B2 (en) | 2020-03-26 | 2024-03-26 | Provectus Pharmatech, Inc. | Halogenated xanthenes as vaccine adjuvants |
| KR20230171854A (ko) * | 2021-04-16 | 2023-12-21 | 프로벡투스 파마테크 인코포레이티드 | 백혈병의 경구 치료를 위한 조성물 및 방법 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3563750A (en) * | 1967-07-20 | 1971-02-16 | Du Pont | Hexaarylbiimidazole hydroxyphthalein compositions |
| US4867973A (en) * | 1984-08-31 | 1989-09-19 | Cytogen Corporation | Antibody-therapeutic agent conjugates |
| US4846789A (en) * | 1982-07-19 | 1989-07-11 | L. S. Van Landingham, Jr. | Combatting internal parasites in warm blooded animals |
| US4490543A (en) | 1982-11-12 | 1984-12-25 | University Of Northern Iowa Foundation | Low toxicity radiation sensitizer |
| US4647578A (en) | 1983-12-02 | 1987-03-03 | Sterling Drug Inc. | Phototoxic insecticidal compositions and method of use thereof |
| WO1986001720A1 (fr) | 1984-09-13 | 1986-03-27 | Cytogen Corporation | Conjugues d'agents therapeutiques-anticorps |
| US5162218A (en) * | 1988-11-18 | 1992-11-10 | The Regents Of The University Of California | Conjugated polypeptides and methods for their preparation |
| US5556992A (en) | 1994-09-02 | 1996-09-17 | Universite De Montreal | Novel rhodamine derivatives for photodynamic therapy of cancer and in vitro purging of the leukemias |
| US5576013A (en) * | 1995-03-21 | 1996-11-19 | Eastern Virginia Medical School | Treating vascular and neoplastic tissues |
| US5780052A (en) | 1995-04-24 | 1998-07-14 | Northeastern University | Compositions and methods useful for inhibiting cell death and for delivering an agent into a cell |
| IT1275571B (it) | 1995-07-19 | 1997-08-07 | Consiglio Nazionale Ricerche | Substrati fluorogenici suscettibili di fotoattivazione previa trasformazione per via enzimatica atti alla diagnosi ed alla terapia fotodinamica dei tumori |
| DE19602295C2 (de) | 1996-01-23 | 2003-08-14 | Deutsches Krebsforsch | Verwendung eines Konjugats aus einer zur Fluoreszenz-fähigen Verbindung, Cyanurchlorid oder einem Derivat davon als Linker und einem Protein |
| US6162931A (en) | 1996-04-12 | 2000-12-19 | Molecular Probes, Inc. | Fluorinated xanthene derivatives |
| WO1998001131A1 (fr) * | 1996-07-05 | 1998-01-15 | Hitachi, Ltd. | Medicaments induisant une action ultrasonore et appareil d'utilisation de ces medicaments |
| US6331286B1 (en) * | 1998-12-21 | 2001-12-18 | Photogen, Inc. | Methods for high energy phototherapeutics |
| US6493570B1 (en) | 1998-11-02 | 2002-12-10 | Photogen, Inc. | Method for improved imaging and photodynamic therapy |
| US7390668B2 (en) * | 1996-10-30 | 2008-06-24 | Provectus Pharmatech, Inc. | Intracorporeal medicaments for photodynamic treatment of disease |
| US6020374A (en) * | 1998-05-14 | 2000-02-01 | Ramot University Authority For Applied Research & Industrial Development Ltd. | Biologically active synthetic dye compounds |
| US7384623B1 (en) * | 1998-12-21 | 2008-06-10 | Provectus Pharmatech, Inc. | High energy phototherapeutic agents |
| US20020001567A1 (en) | 1998-12-21 | 2002-01-03 | Photogen, Inc. | Intracorporeal medicaments for high energy phototherapeutic treatment of disease |
-
2001
- 2001-07-06 US US09/900,355 patent/US7648695B2/en not_active Expired - Fee Related
- 2001-07-10 AU AU2001276860A patent/AU2001276860A1/en not_active Abandoned
- 2001-07-10 MX MXPA03000353A patent/MXPA03000353A/es active IP Right Grant
- 2001-07-10 WO PCT/US2001/021585 patent/WO2002005812A1/fr not_active Ceased
- 2001-07-10 DE DE60132600T patent/DE60132600T2/de not_active Expired - Lifetime
- 2001-07-10 ES ES01954627T patent/ES2300344T3/es not_active Expired - Lifetime
- 2001-07-10 CA CA2415280A patent/CA2415280C/fr not_active Expired - Lifetime
- 2001-07-10 JP JP2002511744A patent/JP4989837B2/ja not_active Expired - Fee Related
- 2001-07-10 AT AT01954627T patent/ATE384522T1/de active
- 2001-07-10 EP EP01954627A patent/EP1311261B1/fr not_active Expired - Lifetime
- 2001-07-13 AR ARP010103340A patent/AR029721A1/es not_active Application Discontinuation
-
2002
- 2002-12-30 US US10/331,735 patent/US20030133940A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20030133940A1 (en) | 2003-07-17 |
| EP1311261B1 (fr) | 2008-01-23 |
| CA2415280A1 (fr) | 2002-01-24 |
| AR029721A1 (es) | 2003-07-10 |
| MXPA03000353A (es) | 2004-01-29 |
| ES2300344T3 (es) | 2008-06-16 |
| US20020161035A1 (en) | 2002-10-31 |
| ATE384522T1 (de) | 2008-02-15 |
| US7648695B2 (en) | 2010-01-19 |
| WO2002005812A1 (fr) | 2002-01-24 |
| CA2415280C (fr) | 2010-06-29 |
| DE60132600T2 (de) | 2009-01-29 |
| JP4989837B2 (ja) | 2012-08-01 |
| DE60132600D1 (de) | 2008-03-13 |
| EP1311261A1 (fr) | 2003-05-21 |
| EP1311261A4 (fr) | 2004-06-02 |
| JP2004503592A (ja) | 2004-02-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001276860A1 (en) | Medicaments for chemotherapeutic treatment of disease | |
| AU2001247615A1 (en) | Intracorporeal medicaments for photodynamic treatment of disease | |
| AU2001235691A1 (en) | Use of paullone derivatives for making medicines | |
| AU2001282873A1 (en) | Quinuclidine-substituted aryl compounds for treatment of disease | |
| EP1455697A4 (fr) | Administration de medicaments par voie vaginale | |
| IL196301A0 (en) | Medicament for the treatment of hapatitis c | |
| AU2001284646A1 (en) | Quinuclidine-substituted heteroaryl moieties for treatment of disease | |
| AU2001282875A1 (en) | Quinuclidine-substituted heteroaryl moieties for treatment of disease | |
| AU2001244188A1 (en) | Medicaments against viral diseases | |
| AU2002222853A1 (en) | Therapeutic compounds | |
| AU2001284645A1 (en) | Quinuclidine-substituted aryl compounds for treatment of disease | |
| AU3009801A (en) | Combinations of medicaments for treating viral diseases | |
| AU2000265525A1 (en) | Medicament for treating intestinal diseases | |
| AU2177001A (en) | Use of indirubine derivatives for making medicines | |
| AU2002312897A1 (en) | Drugs for the treatment of the alzheimer disease | |
| AU2001238346A1 (en) | Modification of biopolymers for improved drug delivery | |
| AU2001248943A1 (en) | Pharmaceutical curative compound | |
| AU2001243515A1 (en) | Combination drug therapy | |
| AU2002322263A1 (en) | Eglin c based drugs for treatment of disease | |
| AU3945501A (en) | Apparatus for dosage of medicaments | |
| AU2002214868A1 (en) | Therapeutic oligonucleotides of reduced toxicity | |
| AU2002210286A1 (en) | Medicine intended for treatment of multiple sclerosis | |
| AU1405001A (en) | Treatment of diseases | |
| AU1618901A (en) | Treatment of rosacea | |
| AU2002215923A1 (en) | Use of medicaments |